Archit Sheth-Shah

Archit Sheth-Shah is a seasoned professional in the biopharmaceutical sector with extensive experience in strategic roles. Currently serving as Senior Director of Portfolio Strategy at Paragon Therapeutics, Inc. since September 2023, Archit previously held the position of Chief Business Officer at Enable Medicine, where significant collaborations were established with leading academic medical centers. Prior experience includes serving as Principal at Roivant Sciences, overseeing therapy licensing and company creation, and playing a pivotal role in strategic initiatives within Roivant Pharma. Additional roles span various industries, including management consulting at Bain & Company, and contributions to healthcare logistics at the Clinton Health Access Initiative. Archit holds a Master of Science in Bioengineering and an MBA from Stanford University, along with a Bachelor of Science in Biomedical Engineering and Economics from Yale University.